Vaporization of leukoplakia type lesions using a diode laser 980 nm – case report

Klaudia Kazubowska, Kamil Jurczyszyn, Natalia Dorosz

Streszczenie
Leukoplakia jest zmianą przednowotworową. Klinicznie charakteryzuje się powstawaniem białych plam lub smug na powierzchni błony śluzowej. Zarówno czynniki miejscowe, jak i ogólne mogą mieć wpływ na jej wystąpienie. Wśród metod leczenia wyróżnia się: metody nieinwazyjne (zachowawcze, farmakologiczne), małoinwazyjne oraz inwazyjne. W pracy przedstawiono małoinwazyjne postępowanie przy usuwaniu zmiany o typie leukoplakii u 61-letniej kobiety, której rozpoznanie kliniczne było potwierdzone histopatologicznie.

Abstract
Leukoplakia is a premalignant lesion, clinically characterized by a white spot. It may be induced by local and general factors. Among the methods of treatment there are noninvasive (conservative, pharmacological), minimally invasive and invasive methods. The study presents a minimally invasive procedure of the removal of leukoplakia type lesion in a 61-year-old woman whose histopathological diagnosis was clinically diagnosed.

Hasła indeksowe: leukoplakia, waporyzacja, leczenie leukoplakii

Key words: leukoplakia, vaporization, leukoplakia treatment

PIŚMIENNICTWO

1. Colella G. i wsp.: Rilievi clinici ed istopatologici su 110 casi di leucoplachia del cavo orale. Minerva Stomatologica, 1991, 40, 357-363.
2. Warnakulasuriya S., Johnson N.W., van der Waal I.: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med., 2007, 36, 10, 575-580.
3. Lodi G., Porter S.: Management of potentially malignant disorders: Evidence and critique. J. Oral Pathol. Med., 2008, 37, 63-69.
4. Sugár L., Bánóczy J.: Follow-up studies in oral leukoplakia. Bull. World Health Organ., 1969, 41, 2, 289-293.
5. Haitami S. i wsp.: Detection of potentially malignant lesions and squamous cell carcinomas in consultation of surgical dentistry. Tunis Med., 2016, 94, 1, 29-33.
6. Dietrich T., Reichart P.A., Scheifele C.: Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol., 2004, 40, 158-163.
7. Kübler A. i wsp.: Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int. J. Oral Maxillofac. Surg., 1998, 27, 466-469.
8. Romeo U. i wsp.: Oral proliferative verrucous leukoplakia treated with the photodynamic therapy: A case report. Ann. Stomatol. (Roma), 2014, 5, 77-80.
9. Shafirstein G. i wsp.: Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch. Otolaryngol. Head Neck Surg., 2011, 137, 1117-1123.
10. van der Waal I.: Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol., 2010, 46, 423-425.
11. Rosin F.C.P. i wsp.: Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia. Lasers Med. Sci., 2017, 32, 379-387.
12. Ribeiro A.S. i wsp.: A review of the nonsurgical treatment of oral leukoplakia. Int. J. Dent., 2010, 2010, 186018.
13. Pietruska M. i wsp.: Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia. Photodiagnosis Photodyn. Ther., 2014, 11, 1, 34-40.
14. Kawczyk-Krupka A. i wsp.: Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia. Photodiagnosis Photodyn. Ther., 2012, 9, 148-155.
15. Vohra F. i wsp.: Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review. Photodiagnosis Photodyn. Ther., 2015, 12, 150-159.
16. Sieroń A. i wsp.: Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J. Oral Pathol. Med., 2003, 32, 330-336.
17. Jurczyszyn K. i wsp.: Assessment of in vivo experiments: The newly synthesized porphyrin with proper light source enhanced effectiveness of PDT comparing to 5-ALA-mediated PDT. Photodiagnosis Photodyn. Ther., 2017, 18, 179-184.
18. Epstein J.B. i wsp.: A survey of the current approaches to diagnosis and management of oral premalignant lesions. J. Am. Dent. Assoc., 2007, 138, 1555-1562.
19. Mamede A.C. i wsp.: The role of vitamins in cancer: A review. Nutr. Cancer, 2011, 63, 479-494.
20. Nagao T. i wsp.: Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: A randomized controlled trial. Int. J. Cancer, 2015, 136, 1708-1717.
21. Ishida C.E., Ramos-e-Silva M.: Cryosurgery in oral lesions. Int. J. Dermatol., 1998, 37, 283-285.
22. Natekar M. i wsp.: A comparative evaluation: Oral leukoplakia surgical management using diode laser, CO2 laser, and cryosurgery. J. Clin. Exp. Dent., 2017, 9, e779-e784.
23. Chen H.-M. i wsp.: Cryogun cryotherapy for oral leukoplakia and adjacent melanosis lesions. J. Oral Pathol. Med., 2015, 44, 607-613.
24. Schoelch M.L. i wsp.: Laser management of oral leukoplakias: A follow-up study of 70 patients. Laryngoscope, 1999, 109, 949-953.
25. Chu F.W., Silverman S., Dedo H.H.: CO2 laser treatment of oral leukoplakia. Laryngoscope, 1988, 98, 125-130.
26. Chiesa F. i wsp.: Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch. Otolaryngol. Head Neck Surg., 1990, 116, 177-180.
27. Ishii J., Fujita K., Komori T.: Laser surgery as a treatment for oral leukoplakia. Oral Oncol., 2003, 39, 759-769.
28. Ishii J. i wsp.: Management of oral leukoplakia by laser surgery: Relation between recurrence and malignant transformation and clinicopathological features. J. Clin. Laser Med. Surg., 2004, 22, 27-33.
29. Akbulut N. i wsp.: Is the 810-nm diode laser the best choice in oral soft tissue therapy? Eur. J. Dent., 2013, 7, 207-211.
30. Kharadi U.A.R. i wsp.: Treatment of oral leukoplakia with diode laser: a pilot study on Indian subjects. Asian Pac. J. Cancer Prev., 2015, 16, 8383-8386.
31. Lodi G. i wsp.: Interventions for treating oral leukoplakia. Cochrane Database Syst. Rev., 2006, CD001829.
32. Del Corso G. i wsp.: Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up. J. Craniomaxillofac. Surg., 2015, 43, 763-768.